Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
J Sports Med Phys Fitness ; 51(2): 268-74, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21681162

RESUMEN

AIM: Even if youths are generally perceived to be healthy, adolescent years are associated with significant morbidity. Screening and counselling programmes seem to be cost-effective but adolescents prefer to rely on health care services for the treatment of diagnosed diseases or injuries rather than for preventive actions. Age oriented studies are needed for better understanding the health needs of adolescents in order to provide an adequate offer of preventive opportunities. METHODS: Eight hundred youths ranging from 13 to 18 years of age were recruited. Health status and risks were clustered into the following five categories: clinical assessment, substance use/abuse, nutritional habits, alcohol and tobacco consumption, physical status. Surprisingly, 33% of the youths were suggested to perform further clinical assessment and even more interestingly a significant number of them received a diagnosis of a symptomatic disorder for which he or she did not previously consider a medical visit to be necessary. RESULTS: As expected, alcohol consumption, tobacco smoking, drug use/abuse and sedentary habit represent the risky lifestyles commonly followed by adolescents. CONCLUSION: The present study confirms the importance of screening programs addressed to health issues and behavioural attitudes of adolescents even in light of the fact that they may underestimate even indicative symptoms.


Asunto(s)
Conductas Relacionadas con la Salud , Tamizaje Masivo , Adolescente , Femenino , Estado de Salud , Humanos , Italia , Estilo de Vida , Masculino , Proyectos Piloto , Factores de Riesgo
2.
Eur J Clin Microbiol Infect Dis ; 29(10): 1277-85, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20602245

RESUMEN

Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasingly being reported among cystic fibrosis (CF) populations worldwide. In this paper, we sought to examine at the epidemiology, the molecular characterisation and the antibiotic resistance of MRSA isolates in our cohort of CF patients. All MRSA strains were collected prospectively at the University Hospital of Catania, Italy, during a two-year study between mid 2005 to mid 2007 and underwent molecular, pathotype and susceptibility characterisations. Our study demonstrates persisting infections with both hospital-associated (HA-) and community-associated (CA-)MRSA, including Panton-Valentine leukocidin (PVL)-positive strains, in our CF population with an overall prevalence of 7.8%. We demonstrated that, in these patients, persistence was sustained by either identical clones that underwent subtle changes in their toxin content or by different clones over time. The isolation of MRSA in our CF population aged 7-24 years was associated with an increased severity of the disease even if, due to the small sample of patients included and the paucity of data on the clinical outcome, these results cannot be conclusive. Furthermore, three strains were heteroresistant vancomycin-intermediate S. aureus (hVISA), questioning the use of glycopeptides in the treatment of MRSA infections in these patients.


Asunto(s)
Fibrosis Quística/complicaciones , Resistencia a la Meticilina , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/efectos de los fármacos , Resistencia a la Vancomicina , Adolescente , Toxinas Bacterianas/genética , Técnicas de Tipificación Bacteriana , Niño , Infecciones Comunitarias Adquiridas/epidemiología , Infecciones Comunitarias Adquiridas/microbiología , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Dermatoglifia del ADN , ADN Bacteriano/genética , Exotoxinas/genética , Genotipo , Humanos , Italia/epidemiología , Leucocidinas/genética , Pruebas de Sensibilidad Microbiana , Estudios Prospectivos , Staphylococcus aureus/aislamiento & purificación , Factores de Virulencia/genética , Adulto Joven
3.
J Clin Microbiol ; 43(10): 5136-42, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16207975

RESUMEN

To analyze national prevalence, genomovar distribution, and epidemiology of the Burkholderia cepacia complex in Italy, 225 putative B. cepacia complex isolates were obtained from 225 cystic fibrosis (CF) patients attending 18 CF centers. The genomovar status of these isolates was determined by a polyphasic approach, which included whole-cell protein electrophoresis and recA restriction fragment length polymorphism (RFLP) analysis. Two approaches were used to genotype B. cepacia complex isolates: BOX-PCR fingerprinting and pulsed-field gel electrophoresis (PFGE) of genomic macrorestriction fragments. A total of 208 (92%) of 225 isolates belonged to the B. cepacia complex, with Burkholderia cenocepacia as the most prevalent species (61.1%). Clones delineated by PFGE were predominantly linked to a single center; in contrast, BOX-PCR clones were composed of isolates collected either from the same center or from different CF centers and comprised multiple PFGE clusters. Three BOX-PCR clones appeared of special interest. One clone was composed of 17 B. cenocepacia isolates belonging to recA RFLP type H. These isolates were collected from six centers and represented three PFGE clusters. The presence of insertion sequence IS 1363 in all isolates and the comparison with PHDC reference isolates identified this clone as PHDC, an epidemic clone prominent in North American CF patients. The second clone included 22 isolates from eight centers and belonged to recA RFLP type AT. The genomovar status of strains with the latter RFLP type is not known. Most of these isolates belonged to four different PFGE clusters. Finally, a third clone comprised nine B. pyrrocinia isolates belonging to recA RFLP type Se 13. They represented three PFGE clusters and were collected in three CF centers.


Asunto(s)
Infecciones por Burkholderia/transmisión , Complejo Burkholderia cepacia/aislamiento & purificación , Fibrosis Quística/epidemiología , Fibrosis Quística/microbiología , Brotes de Enfermedades , Técnicas de Tipificación Bacteriana , Infecciones por Burkholderia/epidemiología , Infecciones por Burkholderia/microbiología , Complejo Burkholderia cepacia/clasificación , Complejo Burkholderia cepacia/genética , Células Clonales , Electroforesis en Gel de Campo Pulsado , Genotipo , Humanos , Italia/epidemiología , Reacción en Cadena de la Polimerasa/métodos , Prevalencia , Esputo/microbiología
4.
J Clin Microbiol ; 39(8): 2891-6, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11474009

RESUMEN

The prevalence, epidemiology, and genomovar status of Burkholderia cepacia complex strains recovered from Italian cystic fibrosis (CF) patients were investigated using genetic typing and species identification methods. Four CF treatment centers were examined: two in Sicily, one in central Italy, and one in northern Italy. B. cepacia complex bacteria were isolated from 59 out of 683 CF patients attending these centers (8.6%). For the two geographically related treatment centers in Sicily, there was a high incidence of infection caused by a single epidemic clone possessing the cblA gene and belonging to B. cepacia genomovar III, recA group III-A, closely related to the major North America-United Kingdom clone, ET12; instability of the cblA sequence was also demonstrated for clonal isolates. In summary, of all the strains of B. cepacia encountered in the Italian CF population, the genomovar III, recA group III-A strains were the most prevalent and transmissible. However, patient-to-patient spread was also observed with several other genomovars, including strains of novel taxonomic status within the B. cepacia complex. A combination of genetic identification and molecular typing analysis is recommended to fully define specific risks posed by the genomovar status of strains within the B. cepacia complex.


Asunto(s)
Infecciones por Burkholderia/complicaciones , Burkholderia cepacia/clasificación , Burkholderia cepacia/genética , Fibrosis Quística/complicaciones , Proteínas de Neoplasias , Proteoglicanos , Técnicas de Tipificación Bacteriana/métodos , Infecciones por Burkholderia/epidemiología , Infecciones por Burkholderia/microbiología , Fibrosis Quística/microbiología , ADN Ribosómico/análisis , Electroforesis en Gel de Campo Pulsado , Proteínas Fimbrias , Genes de ARNr , Humanos , Italia/epidemiología , Proteínas de la Membrana/genética , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Prevalencia , Proteínas , Rec A Recombinasas/genética
5.
New Microbiol ; 23(3): 319-27, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10939047

RESUMEN

This study addresses the epidemiologic relatedness of a collection of Pseudomonas aeruginosa isolates from cystic fibrosis patients attending the Pediatric Clinic, Catania, Sicily. Genome macrorestriction analysis after pulsed field gel electrophoresis (PFGE) was used to characterise all strains. Furthermore, a rapid typing procedure, developed in this study, based on polymerase chain reaction amplified ribosomal DNA spacer polymorphisms (PCR-ribotyping), straight from bacterial cultures, was used. On the basis of macrorestriction analysis after PFGE, persistence of infection was shown in all patients; two cross-transmission episodes were identified in the nosocomial as well as in the familiar environment. PCR-ribotyping proved to be useful for a DNA-based identification test, suitable for screening purposes. The rapid amplification protocol here tested is proposed to evaluate the discriminatory power of other specific target sequences in PCR-based typing assays, for epidemiologic purposes.


Asunto(s)
Fibrosis Quística/microbiología , Genoma Bacteriano , Infecciones por Pseudomonas/epidemiología , Pseudomonas aeruginosa/genética , Mapeo Restrictivo , Ribotipificación , Adolescente , Antibacterianos/farmacología , Niño , Preescolar , Fibrosis Quística/complicaciones , ADN Bacteriano/genética , ADN Bacteriano/metabolismo , ADN Intergénico/genética , ADN Intergénico/metabolismo , ADN Ribosómico/genética , ADN Ribosómico/metabolismo , Desoxirribonucleasas de Localización Especificada Tipo II/metabolismo , Farmacorresistencia Microbiana , Femenino , Genotipo , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Infecciones por Pseudomonas/complicaciones , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/transmisión , Pseudomonas aeruginosa/clasificación , Pseudomonas aeruginosa/efectos de los fármacos , Sicilia
6.
J Pediatr Gastroenterol Nutr ; 24(5): 559-62, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9161952

RESUMEN

BACKGROUND: We carried out a study of the antibody pattern in 50 celiac children [34 females (F) and 16 males (M); F/M, 2.1], ages 7 months-15 years, compared with that in 25 control subjects (13 females and 12 males) of the same age. METHODS: IgA and IgG antigliadin antibodies (AGA) were determined with an enzyme-linked immunosorbent assay technique. IgA anti-R1-reticulin antibodies (ARA) and IgA antiendomysium antibodies (EmA) were determined with the fluorescein isothiocyanate-conjugate-labeled anti-human immunoglobulin technique. To compare sensitivity and specificity, EmA were identified using monkey esophagus and human umbilical cord as substrates. RESULTS: While AGA (IgA and IgG) showed a high sensitivity but a low specificity, ARA showed a high specificity but a low sensitivity. Data on EmA showed a high sensitivity and specificity with both tissue sections, with monkey esophagus being more sensitive (96%) and umbilical cord more specific (100%). CONCLUSIONS: Our results confirm the importance of celiac disease-related antibodies in identifying celiac children. Moreover, the easy availability of human umbilical cord indicates that it would be proper to use this tissue as substrate, instead of monkey esophagus, for EmA search in the future.


Asunto(s)
Enfermedad Celíaca/inmunología , Gliadina/inmunología , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Miofibrillas/inmunología , Reticulina/inmunología , Adolescente , Animales , Biopsia , Enfermedad Celíaca/sangre , Niño , Preescolar , Ensayo de Inmunoadsorción Enzimática , Esófago/inmunología , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Haplorrinos , Humanos , Inmunoglobulina A/inmunología , Inmunoglobulina G/inmunología , Lactante , Masculino , Valores de Referencia , Cordón Umbilical/inmunología , Cordón Umbilical/patología
7.
Bone Marrow Transplant ; 19(2): 157-60, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9116613

RESUMEN

We evaluated the immune status with respect to HBV and the immune response to readministration of HBV vaccine in a series of 20 patients with homozygous beta-thalassemia, aged 6-23 years (mean age: 13.0 +/- 4.2) who had undergone allogeneic bone marrow transplantation (BMT). Thirteen of them (group A), had received three doses of plasma-derived HBV vaccine from 7 to 5 years before BMT and 4-5 weeks after the last dose of vaccine, they had had high serum levels of HBV antibodies (anti-HBs). The remaining seven patients (group B) had had clinical symptoms and laboratory evidence of HBV infection in childhood with markedly elevated serum of anti-HBs. Before revaccination, a significantly lower percentage of patients (P < 0.005) with seropositive levels of anti-HBs was observed in group A than in group B. After administration of the second dose of HBV vaccine the percentage of subjects with protective levels of anti-HBs rose to 100% in both groups of patients even if the geometric mean of titers of anti-HBs increased more significantly in group B patients than in group A. We conclude that the serum levels of anti-HBs afforded by HBV vaccine administered from 7 to 5 years previously are very low and probably non-protective in most beta-thalassemic patients after allogeneic BMT, and that at least two doses of HBV vaccine should be readministered from 18 to 24 months after BMT to achieve adequate and long-term protection from HBV.


Asunto(s)
Trasplante de Médula Ósea/inmunología , Vacunas contra Hepatitis B/administración & dosificación , Hepatitis B/inmunología , Inmunidad , Talasemia beta , Adolescente , Adulto , Trasplante de Médula Ósea/efectos adversos , Niño , Hepatitis B/etiología , Hepatitis B/prevención & control , Humanos , Trasplante Homólogo , Talasemia beta/inmunología , Talasemia beta/terapia
8.
Eur J Pediatr ; 153(4): 271-5, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8194562

RESUMEN

A group of 90 patients with acute lymphoblastic leukaemia (ALL) in first continuous complete remission (CCR), admitted in our hospital between January 1986 and September 1992, were tested for the presence of antibodies against hepatitis C virus (HCV), antibodies against hepatitis B virus and antibodies against HIV-1 during maintenance therapy or thereafter. They were compared with a group of 71 children with other malignancies in first CCR who had been diagnosed consecutively from January 1986 to September 1992. No patient with ALL or any other malignancy was found to be positive for hepatitis B surface antigen or HIV-1. HCV-specific antibodies were detected in 28 out of 87 children (32.1%) with ALL and in 4 out of 44 patients (9%) with malignancies other than ALL who had received at least one transfusion of blood or platelets (P < 0.01). HCV-specific antibodies were also detected in one out of three untransfused children with ALL but in none of the untransfused children with malignancies other than ALL. HCV-specific seropositivity influenced the management of children with ALL during maintenance therapy. In fact, as a result of abnormal liver function tests, maintenance therapy had to be suspended significantly more often in the case of HCV-seropositive patients with ALL than in HCV-seronegative ones. Despite the high morbidity during maintenance therapy, chronic liver disease (CLD) was uncommon in both groups: five children with ALL (17.2% of HCV-seropositive children) and one child with a malignancy other than ALL (25%) had CLD.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Hepatitis C/epidemiología , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Adolescente , Niño , Preescolar , Enfermedad Crónica , Anticuerpos Antihepatitis/sangre , Hepatitis C/etiología , Hepatitis C/inmunología , Humanos , Incidencia , Lactante , Recién Nacido , Hepatopatías/etiología , Pruebas de Función Hepática
9.
G Ital Cardiol ; 19(12): 1119-24, 1989 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2634565

RESUMEN

Detailed QRS wave analysis from the limb leads of the surface high resolution electrocardiograms recorded in five cyclosporine-treated heart transplant recipients gave good correlation with the corresponding results of endomyocardial biopsy. That is when the result of the biopsies has identified the presence of rejection, a concomitant (p = 0.001) variation in some parameters of the QRS has been observed. The reproducibility of such parameters (established by means of the correlation coefficient r) gave r values ranging from 0.6 up to 0.93. The correlation regarded parameters analyzed both in time and frequency domain. Biopsy results were divided into two classes on the basis of the presence or absence of rejection. The most significant parameters obtained from high-frequency (25-300 Hz) ECGs within a few hours of each biopsy were: a) the total high-frequency voltage amplitude Vt of the QRS and the voltage amplitude of its initial Vi and middle thirds Vm; b) the peak voltage amplitude Vp of the QRS; c) the QRS duration L; d) the integrated voltage time product I of the QRS; e) three mean voltage amplitudes V5, V6, V7, of the power spectral density constructed on the basis of the 512-point fast Fourier transform applied on each recording. The above mentioned parameters appear to be useful in predicting the biopsy result in terms of the presence or absence of rejection.


Asunto(s)
Electrocardiografía/métodos , Rechazo de Injerto , Trasplante de Corazón , Adolescente , Adulto , Biopsia , Niño , Preescolar , Ciclosporinas/uso terapéutico , Endocardio/patología , Femenino , Análisis de Fourier , Rechazo de Injerto/efectos de los fármacos , Corazón/fisiopatología , Trasplante de Corazón/patología , Humanos , Masculino , Persona de Mediana Edad
10.
Pediatr Med Chir ; 10(4): 409-13, 1988.
Artículo en Italiano | MEDLINE | ID: mdl-3231548

RESUMEN

Antigliadin antibodies (AGA), both IgA and IgG, were studied in the serum of 84 coeliac children during the various stage (Diagnosis, GFD, Challenge) and in 29 healthy children, with a micro-ELISA technique. The results demonstrated the presence of AGA in the serum of coeliac children and a different behaviour between the two Ig-classes in the various stages of the disease. During acute phase both classes were present at high titre. When gluten was withdrawal from the diet, while the titre of IgA fell rapidly since the first month, the IgG titre decreased slowly and raised the normal limits after six months. If the children didn't observe a corrected GFD, the serum AGA titres remained at high levels. During challenge, while IgG raised since the early days, IgA titres raised later, when the intestinal damage became important. The explanation of this different behaviour could be that AGA-IgA are derived from gut mucosa, on the contrary AGA-IgG are not synthesised in the intestine. We believe that serum AGA seem to be good markers of the immune reaction in the intestine triggered by gluten. Furthermore we conclude that the assay of AGA in the serum of coeliac patients is: 1) high sensible and specific method; 2) the most important screening test for intestinal biopsy; 3) the most important test for diagnosis and follow-up of CD; 4) the test which could substitute 1 or 2 intestinal biopsies of the ESPGAN protocol.


Asunto(s)
Enfermedad Celíaca/inmunología , Gliadina/inmunología , Inmunoglobulina A/análisis , Inmunoglobulina G/análisis , Proteínas de Plantas/inmunología , Adolescente , Enfermedad Celíaca/diagnóstico , Niño , Preescolar , Humanos , Inmunoglobulina A/inmunología , Inmunoglobulina G/inmunología , Pruebas Inmunológicas , Lactante
11.
Boll Soc Ital Biol Sper ; 57(14): 1528-31, 1981 Jul 30.
Artículo en Italiano | MEDLINE | ID: mdl-7028056

RESUMEN

Fragments of temporal artery obtained by surgical biopsy from 3 patients suffering from Horton arteritis were employed for immunopathologic studies by direct immunofluorescence. In 2 of the cases, granular deposition of IgM, C1q and C3 but not of albumin were observed in the wall of vasa vasorum of the temporal artery. Elution techniques determined the disappearance of the immunoreactants. In one case in which biopsy fragments of temporal artery were obtained prior to and after steroid treatment it was observed that IgM and complement, previously present, disappeared after such treatment. The data reported indicate that indeed immunologic factors play a role in the pathogenesis of the disease and that the immunoreagents present on the wall of vasa vasorum are not evidence of increased vascular permeability but indicate an active immunologic process which takes place in them.


Asunto(s)
Arteritis de Células Gigantes/inmunología , Albúminas/análisis , Enzimas Activadoras de Complemento/análisis , Complemento C1q , Complemento C3/análisis , Técnica del Anticuerpo Fluorescente , Arteritis de Células Gigantes/patología , Humanos , Inmunoglobulina M/análisis , Arterias Temporales/patología
12.
Minerva Med ; 70(40): 2735-40, 1979 Sep 22.
Artículo en Italiano | MEDLINE | ID: mdl-481796

RESUMEN

A brief account of the physiopathology of proteinuria is followed by a description of the diagnostic routine to be followed in such cases, with particular reference to the electrophoretic study of urinary proteins. In many cases, this simple method gives information on a par with that offered by biopsy, especially insofar as the planning of treatment is concerned. Several clinical cases are cited by way of illustration.


Asunto(s)
Proteinuria/diagnóstico , Adolescente , Adulto , Anciano , Niño , Electroforesis , Femenino , Glomerulonefritis/diagnóstico , Humanos , Masculino , Síndrome Nefrótico/diagnóstico , Proteinuria/fisiopatología , Pielonefritis/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA